Typical attendees include science-based professionals: biologists, molecular biologists, chemists, preclinical development scientists, informaticians, patent attorneys, project managers, general managers and technology transfer managers.

A one day course.

The course is a ‘one-stop-shop’ outlining the major scientific tools of drug discovery, namely: Drug Discovery Biology, ADMET/PK/PD, Medicinal Chemistry, Informatics/Virtual technologies. It shows how these contributions are phased over time and integrated to generate a drug suitable for transfer to the Preclinical-Clinical Development Group.

The focus is on small molecule drugs with comparisons made with biologics. Based on real-world experience and practical realities, attendees travel step-by-step along a typical drug discovery path, namely: Initiating Idea -> Drug Target Protein Selection -> Lead Identification -> Clinical Candidate Nomination. 

Essential related topics include drug discovery technology platforms, drug structural-functional quality attributes and Project management tools. Key existing and emerging technologies, infrastructure and essential skills requirements are also covered in the course.

You can see the full course contents here.

You can read a Backgrounder to the course here. 

Gold Members: £392 + VAT
Silver Members: £476 + VAT
Non-members: £560 + VAT